Trulieve Cannabis (TCNNF) Non-Current Assets (2020 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Non-Current Assets of $2.1 billion in Q1 2026, little changed quarter-over-quarter from $2.1 billion in Q4 2025, and down 4.88% on a YoY basis from $2.2 billion in Q1 2025.
Trulieve Cannabis (TCNNF) Non-Current Assets (2020 - 2026) Analysis & Trends
Trulieve Cannabis' Non-Current Assets history runs 7 years deep, the most recent figure standing at $2.1 billion for Q1 2026.
- In Q1 2026, Non-Current Assets fell 4.88% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $8.7 billion (down 3.9% YoY), while the FY2025 annual figure was $2.1 billion, down 5.84% from the prior year.
- Non-Current Assets was $2.1 billion for Q1 2026 at Trulieve Cannabis, roughly flat from $2.1 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $2.9 billion in Q2 2022 to a low of $2.1 billion in Q1 2026.
- Historically, Non-Current Assets has averaged $2.4 billion across 5 years, with a median of $2.3 billion in 2024.
- The sharpest annual moves came in 2022 and 2023: Non-Current Assets surged 379.45% in 2022, then slipped 20.46% in 2023.
- A 5-year view of Non-Current Assets shows it stood at $2.8 billion in 2022, then decreased by 19.78% to $2.3 billion in 2023, then gained by 0.62% to $2.3 billion in 2024, then fell by 5.84% to $2.1 billion in 2025, then slipped by 0.21% to $2.1 billion in 2026.
- The last three Non-Current Assets figures came in at $2.1 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | 2.13 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.13 Bn |
| Dec 31, 2025 | 2.13 Bn |
| Sep 30, 2025 | 2.19 Bn |
| Jun 30, 2025 | 2.21 Bn |
| Mar 31, 2025 | 2.24 Bn |
| Dec 31, 2024 | 2.27 Bn |
| Sep 30, 2024 | 2.27 Bn |
| Jun 30, 2024 | 2.23 Bn |
| Mar 31, 2024 | 2.23 Bn |
| Dec 31, 2023 | 2.25 Bn |
| Sep 30, 2023 | 2.29 Bn |
| Jun 30, 2023 | 2.33 Bn |
| Mar 31, 2023 | 2.74 Bn |
| Dec 31, 2022 | 2.81 Bn |
| Sep 30, 2022 | 2.83 Bn |
| Jun 30, 2022 | 2.93 Bn |
| Mar 31, 2022 | 2.93 Bn |
| Dec 31, 2021 | 2.89 Bn |
| Sep 30, 2021 | 890.34 Mn |
| Jun 30, 2021 | 723.24 Mn |